Author:
Blackledge G.,van Oosterom A.,Mouridsen H.T.,Bramwell V.,Santoro A.,Verweij J.,Rouëssé J.,Somers R.,Wagener T.,Buesa J.,Steward W.P.,Spooner D.,van Unnik J.,Thomas D.,Sylvester R.
Subject
Radiology Nuclear Medicine and imaging,Oncology
Reference23 articles.
1. Can the activity of doxorubicin in recurrent and previously chemotherapy-treated soft tissue sarcoma justify extensive phase II evaluation of new drugs in this disease? An EORTC Soft Tissue and Bone Sarcoma Group study;Blackledge;European Journal of Cancer and Clinical Oncology,1989
2. A phase II study of m-azidopyrimethamine ethane sulphonate (MZPES) in advanced, recurrent soft tissue sarcoma: An EORTC Soft Tissue and Bone Sarcoma Group study;Blackledge;European Journal of Cancer and Clinical Oncology,1989
3. EORTC Phase II study of cisplatin in CyVADIC resistant soft tissue sarcoma;Bramwell;European Journal of Cancer,1979
4. Phosphonacetyl-L-aspartate (PALA) in advanced soft tissue sarcoma: a phase II trial of the EORTC Soft Tissue and Bone Sarcoma Group;Bramwell;European Journal of Cancer and Clinical Oncology,1982
5. Carminomycin versus adriamycin in advanced soft tissue sarcomas: an EORTC randomized phase II study;Bramwell;European Journal of Cancer and Clinical Oncology,1983
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献